ACIP Stops Short of Requiring Doctor's Prescription for COVID Vaccine
The vaccine advisory panel for the CDC “fine-tuned its COVID vaccine recommendations and narrowly rejected its working group’s proposal to require a doctor’s prescription for the vaccine.” CIDRAP has the news.
The measure that would have added barriers to vaccination “was a proposal that would have advised states and localities to require a doctor’s prescription for COVID vaccine for all groups, which in the initial vote was a 6-to-6 tie.” Liaison members and some members of ACIP itself throughout the proceedings raised concerns about the “lack and quality of evidence” backing the proposals.
Many of the members who voted against the main measure “worried that a prescription would be a barrier to immunization, especially for people who don’t have regular doctors and those in underserved areas, many of whom they said are in the groups at higher risk for severe COVID illness. They also aired concerns about adding an extra burden to already busy doctor’s offices. Those who voted for the measure, however, said the doctor’s prescription was needed to ensure that patients are adequately informed of the risks and benefits of vaccination.”
Other measures addressed by the group included deciding that “adults age 65 and older should be vaccinated based on their own assessment and emphasized that, for people ages 6 months to 64 years old, the vaccination benefit is most favorable for those with underlying health conditions.” Members of the panel (handpicked by HHS secretary Robert F. Kennedy, Jr.) trying to scale back access to the COVID vaccine focused on “the safety concerns, the effectiveness of the vaccines, a purported lack of research, and several uncertainties, including whether the vaccine causes long-term health problems that are similar to long COVID.”
About the Author
Matt MacKenzieMatt MacKenzie
Associate Editor
Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care.
Related
cdc_4
Dreamstime Xs 180826012